Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 193 entries
Sorted by: Best Match Show Resources per page
[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Misrai V, Kerever S, Bordier B, Bruyère F, Karsenty G, Guillotreau J.
PMID: 26544221
Prog Urol. 2015 Nov;25(13):728. doi: 10.1016/j.purol.2015.08.026.

No abstract available.

Cite
Misrai V, Kerever S, Bordier B, et al. Comparaison des résultats de l'énucléation en bloc de la prostate au laser greenlight et de la photovaporisation prostatique dans le traitement des adénomes de gros volumes. [Not Available]. Prog Urol. 2015;25(13):728doi: 10.1016/j.purol.2015.08.026.
Misrai, V., Kerever, S., Bordier, B., Bruyère, F., Karsenty, G., & Guillotreau, J. (2015). Comparaison des résultats de l'énucléation en bloc de la prostate au laser greenlight et de la photovaporisation prostatique dans le traitement des adénomes de gros volumes. [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 25(13), 728. https://doi.org/10.1016/j.purol.2015.08.026
Misrai, V, et al. "Comparaison des résultats de l'énucléation en bloc de la prostate au laser greenlight et de la photovaporisation prostatique dans le traitement des adénomes de gros volumes." [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie vol. 25,13 (2015): 728. doi: https://doi.org/10.1016/j.purol.2015.08.026
Misrai V, Kerever S, Bordier B, Bruyère F, Karsenty G, Guillotreau J. Comparaison des résultats de l'énucléation en bloc de la prostate au laser greenlight et de la photovaporisation prostatique dans le traitement des adénomes de gros volumes. [Not Available]. Prog Urol. 2015 Nov;25(13):728. doi: 10.1016/j.purol.2015.08.026. French. PMID: 26544221.
Copy Download .nbib Format: NLM
Correction to: household preferences for reducing greenhouse gas emissions in four European high-income countries: does health information matter? A mixed-methods study protocol.

BMC public health

Herrmann A, Fischer H, Amelung D, Litvine D, Aall C, Andersson C, Baltruszewicz M, Barbier C, Bruyère S, Bénévise F, Dubois G, Louis VR, Nilsson M, Moberg KR, Sköld B, Sauerborn R.
PMID: 29070015
BMC Public Health. 2017 Oct 25;17(1):846. doi: 10.1186/s12889-017-4861-z.

No abstract available.

Cite
Herrmann A, Fischer H, Amelung D, et al. Correction to: household preferences for reducing greenhouse gas emissions in four European high-income countries: does health information matter? A mixed-methods study protocol. BMC Public Health. 2017;17(1):846doi: 10.1186/s12889-017-4861-z.
Herrmann, A., Fischer, H., Amelung, D., Litvine, D., Aall, C., Andersson, C., Baltruszewicz, M., Barbier, C., Bruyère, S., Bénévise, F., Dubois, G., Louis, V. R., Nilsson, M., Moberg, K. R., Sköld, B., & Sauerborn, R. (2017). Correction to: household preferences for reducing greenhouse gas emissions in four European high-income countries: does health information matter? A mixed-methods study protocol. BMC public health, 17(1), 846. https://doi.org/10.1186/s12889-017-4861-z
Herrmann, Alina, et al. "Correction to: household preferences for reducing greenhouse gas emissions in four European high-income countries: does health information matter? A mixed-methods study protocol." BMC public health vol. 17,1 (2017): 846. doi: https://doi.org/10.1186/s12889-017-4861-z
Herrmann A, Fischer H, Amelung D, Litvine D, Aall C, Andersson C, Baltruszewicz M, Barbier C, Bruyère S, Bénévise F, Dubois G, Louis VR, Nilsson M, Moberg KR, Sköld B, Sauerborn R. Correction to: household preferences for reducing greenhouse gas emissions in four European high-income countries: does health information matter? A mixed-methods study protocol. BMC Public Health. 2017 Oct 25;17(1):846. doi: 10.1186/s12889-017-4861-z. PMID: 29070015; PMCID: PMC5657105.
Copy Download .nbib Format: NLM
Macro-economic factors influencing the architectural business model shift in the pharmaceutical industry.

Expert review of pharmacoeconomics & outcomes research

Dierks RM, Bruyère O, Reginster JY, Richy FF.
PMID: 27653356
Expert Rev Pharmacoecon Outcomes Res. 2016 Oct;16(5):571-578. doi: 10.1080/14737167.2016.1239534. Epub 2016 Oct 04.

INTRODUCTION: Technological innovations, new regulations, increasing costs of drug productions and new demands are only few key drivers of a projected alternation in the pharmaceutical industry. The purpose of this review is to understand the macro economic factors responsible...

Cite
Dierks RM, Bruyère O, Reginster JY, et al. Macro-economic factors influencing the architectural business model shift in the pharmaceutical industry. Expert Rev Pharmacoecon Outcomes Res. 2016;16(5):571-578doi: 10.1080/14737167.2016.1239534.
Dierks, R. M., Bruyère, O., Reginster, J. Y., & Richy, F. F. (2016). Macro-economic factors influencing the architectural business model shift in the pharmaceutical industry. Expert review of pharmacoeconomics & outcomes research, 16(5), 571-578. https://doi.org/10.1080/14737167.2016.1239534
Dierks, Raphaela Marie Louisa, et al. "Macro-economic factors influencing the architectural business model shift in the pharmaceutical industry." Expert review of pharmacoeconomics & outcomes research vol. 16,5 (2016): 571-578. doi: https://doi.org/10.1080/14737167.2016.1239534
Dierks RM, Bruyère O, Reginster JY, Richy FF. Macro-economic factors influencing the architectural business model shift in the pharmaceutical industry. Expert Rev Pharmacoecon Outcomes Res. 2016 Oct;16(5):571-578. doi: 10.1080/14737167.2016.1239534. Epub 2016 Oct 04. PMID: 27653356.
Copy Download .nbib Format: NLM
Mobile Phone-Connected Wearable Motion Sensors to Assess Postoperative Mobilization.

JMIR mHealth and uHealth

Appelboom G, Taylor BE, Bruce E, Bassile CC, Malakidis C, Yang A, Youngerman B, D'Amico R, Bruce S, Bruyère O, Reginster JY, Dumont EP, Connolly ES.
PMID: 26220691
JMIR Mhealth Uhealth. 2015 Jul 28;3(3):e78. doi: 10.2196/mhealth.3785.

BACKGROUND: Early mobilization after surgery reduces the incidence of a wide range of complications. Wearable motion sensors measure movements over time and transmit this data wirelessly, which has the potential to monitor patient recovery and encourages patients to engage...

Cite
Appelboom G, Taylor BE, Bruce E, et al. Mobile Phone-Connected Wearable Motion Sensors to Assess Postoperative Mobilization. JMIR Mhealth Uhealth. 2015;3(3):e78doi: 10.2196/mhealth.3785.
Appelboom, G., Taylor, B. E., Bruce, E., Bassile, C. C., Malakidis, C., Yang, A., Youngerman, B., D'Amico, R., Bruce, S., Bruyère, O., Reginster, J. Y., Dumont, E. P., & Connolly, E. S. (2015). Mobile Phone-Connected Wearable Motion Sensors to Assess Postoperative Mobilization. JMIR mHealth and uHealth, 3(3), e78. https://doi.org/10.2196/mhealth.3785
Appelboom, Geoff, et al. "Mobile Phone-Connected Wearable Motion Sensors to Assess Postoperative Mobilization." JMIR mHealth and uHealth vol. 3,3 (2015): e78. doi: https://doi.org/10.2196/mhealth.3785
Appelboom G, Taylor BE, Bruce E, Bassile CC, Malakidis C, Yang A, Youngerman B, D'Amico R, Bruce S, Bruyère O, Reginster JY, Dumont EP, Connolly ES. Mobile Phone-Connected Wearable Motion Sensors to Assess Postoperative Mobilization. JMIR Mhealth Uhealth. 2015 Jul 28;3(3):e78. doi: 10.2196/mhealth.3785. PMID: 26220691; PMCID: PMC4705357.
Copy Download .nbib Format: NLM
JLK1486, a Bis 8-Hydroxyquinoline-Substituted Benzylamine, Displays Cytostatic Effects in Experimental Gliomas through MyT1 and STAT1 Activation and, to a Lesser Extent, PPARγ Activation.

Translational oncology

Bruyère C, Madonna S, Van Goietsenoven G, Mathieu V, Dessolin J, Kraus JL, Lefranc F, Kiss R.
PMID: 21633668
Transl Oncol. 2011 Jun;4(3):126-37. doi: 10.1593/tlo.10253. Epub 2011 Jun 01.

Gliomas account for 5% to 7% of all solid cancers in adults and up to 30% of solid cancers in children; glioblastomas are the most malignant type of glioma and often have dismal prognoses. The alkylating agent temozolomide provides...

Cite
Bruyère C, Madonna S, Van Goietsenoven G, et al. JLK1486, a Bis 8-Hydroxyquinoline-Substituted Benzylamine, Displays Cytostatic Effects in Experimental Gliomas through MyT1 and STAT1 Activation and, to a Lesser Extent, PPARγ Activation. Transl Oncol. 2011;4(3):126-37doi: 10.1593/tlo.10253.
Bruyère, C., Madonna, S., Van Goietsenoven, G., Mathieu, V., Dessolin, J., Kraus, J. L., Lefranc, F., & Kiss, R. (2011). JLK1486, a Bis 8-Hydroxyquinoline-Substituted Benzylamine, Displays Cytostatic Effects in Experimental Gliomas through MyT1 and STAT1 Activation and, to a Lesser Extent, PPARγ Activation. Translational oncology, 4(3), 126-37. https://doi.org/10.1593/tlo.10253
Bruyère, Céline, et al. "JLK1486, a Bis 8-Hydroxyquinoline-Substituted Benzylamine, Displays Cytostatic Effects in Experimental Gliomas through MyT1 and STAT1 Activation and, to a Lesser Extent, PPARγ Activation." Translational oncology vol. 4,3 (2011): 126-37. doi: https://doi.org/10.1593/tlo.10253
Bruyère C, Madonna S, Van Goietsenoven G, Mathieu V, Dessolin J, Kraus JL, Lefranc F, Kiss R. JLK1486, a Bis 8-Hydroxyquinoline-Substituted Benzylamine, Displays Cytostatic Effects in Experimental Gliomas through MyT1 and STAT1 Activation and, to a Lesser Extent, PPARγ Activation. Transl Oncol. 2011 Jun;4(3):126-37. doi: 10.1593/tlo.10253. Epub 2011 Jun 01. PMID: 21633668; PMCID: PMC3105292.
Copy Download .nbib Format: NLM
Letter to the editor.

Seminars in arthritis and rheumatism

Bruyère O, Reginster JY.
PMID: 25300702
Semin Arthritis Rheum. 2015 Apr;44(5):e15. doi: 10.1016/j.semarthrit.2014.09.001. Epub 2014 Sep 06.

No abstract available.

Cite
Bruyère O, Reginster JY. Letter to the editor. Semin Arthritis Rheum. 2014;44(5):e15doi: 10.1016/j.semarthrit.2014.09.001.
Bruyère, O., & Reginster, J. Y. (2015). Letter to the editor. Seminars in arthritis and rheumatism, 44(5), e15. https://doi.org/10.1016/j.semarthrit.2014.09.001
Bruyère, Olivier, and Reginster, Jean-Yves. "Letter to the editor." Seminars in arthritis and rheumatism vol. 44,5 (2015): e15. doi: https://doi.org/10.1016/j.semarthrit.2014.09.001
Bruyère O, Reginster JY. Letter to the editor. Semin Arthritis Rheum. 2015 Apr;44(5):e15. doi: 10.1016/j.semarthrit.2014.09.001. Epub 2014 Sep 06. PMID: 25300702.
Copy Download .nbib Format: NLM
3-{3,5-Bis[(2-but-oxy-eth-oxy)carbon-yl]-2,6-dimethyl-1,4-dihydro-pyridin-4-yl}-1-[(3,4,5-trimeth-oxy-benzo-yl)meth-yl]pyridinium bromide.

Acta crystallographica. Section E, Structure reports online

Bisenieks I, Mishnev A, Bruvere I, Vigante B.
PMID: 23476440
Acta Crystallogr Sect E Struct Rep Online. 2013 Jan 01;69:o58-9. doi: 10.1107/S1600536812049896. Epub 2012 Dec 08.

In the title salt, C37H51N2O10(+)·Br(-), the 1,4-dihydro-pyridine (1,4-DHP) ring adopts a slighly puckered boat conformation. The N and opposite C atoms deviate from the least-squares plane calculated through the four other ring atoms by 0.068 (5) and 0.224 (5)...

Cite
Bisenieks I, Mishnev A, Bruvere I, et al. 3-{3,5-Bis[(2-but-oxy-eth-oxy)carbon-yl]-2,6-dimethyl-1,4-dihydro-pyridin-4-yl}-1-[(3,4,5-trimeth-oxy-benzo-yl)meth-yl]pyridinium bromide. Acta Crystallogr Sect E Struct Rep Online. 2012;69:o58-9doi: 10.1107/S1600536812049896.
Bisenieks, I., Mishnev, A., Bruvere, I., & Vigante, B. (2013). 3-{3,5-Bis[(2-but-oxy-eth-oxy)carbon-yl]-2,6-dimethyl-1,4-dihydro-pyridin-4-yl}-1-[(3,4,5-trimeth-oxy-benzo-yl)meth-yl]pyridinium bromide. Acta crystallographica. Section E, Structure reports online, 69o58-9. https://doi.org/10.1107/S1600536812049896
Bisenieks, Imants, et al. "3-{3,5-Bis[(2-but-oxy-eth-oxy)carbon-yl]-2,6-dimethyl-1,4-dihydro-pyridin-4-yl}-1-[(3,4,5-trimeth-oxy-benzo-yl)meth-yl]pyridinium bromide." Acta crystallographica. Section E, Structure reports online vol. 69 (2013): o58-9. doi: https://doi.org/10.1107/S1600536812049896
Bisenieks I, Mishnev A, Bruvere I, Vigante B. 3-{3,5-Bis[(2-but-oxy-eth-oxy)carbon-yl]-2,6-dimethyl-1,4-dihydro-pyridin-4-yl}-1-[(3,4,5-trimeth-oxy-benzo-yl)meth-yl]pyridinium bromide. Acta Crystallogr Sect E Struct Rep Online. 2013 Jan 01;69:o58-9. doi: 10.1107/S1600536812049896. Epub 2012 Dec 08. PMID: 23476440; PMCID: PMC3588226.
Copy Download .nbib Format: NLM
Republished: Value of biomarkers in osteoarthritis: current status and perspectives.

Postgraduate medical journal

Lotz M, Martel-Pelletier J, Christiansen C, Brandi ML, Bruyère O, Chapurlat R, Collette J, Cooper C, Giacovelli G, Kanis JA, Karsdal MA, Kraus V, Lems WF, Meulenbelt I, Pelletier JP, Raynauld JP, Reiter-Niesert S, Rizzoli R, Sandell LJ, Van Spil WE, Reginster JY.
PMID: 24534711
Postgrad Med J. 2014 Mar;90(1061):171-8. doi: 10.1136/postgradmedj-2013-203726rep.

Osteoarthritis affects the whole joint structure with progressive changes in cartilage, menisci, ligaments and subchondral bone, and synovial inflammation. Biomarkers are being developed to quantify joint remodelling and disease progression. This article was prepared following a working meeting of...

Cite
Lotz M, Martel-Pelletier J, Christiansen C, et al. Republished: Value of biomarkers in osteoarthritis: current status and perspectives. Postgrad Med J. 2014;90(1061):171-8doi: 10.1136/postgradmedj-2013-203726rep.
Lotz, M., Martel-Pelletier, J., Christiansen, C., Brandi, M. L., Bruyère, O., Chapurlat, R., Collette, J., Cooper, C., Giacovelli, G., Kanis, J. A., Karsdal, M. A., Kraus, V., Lems, W. F., Meulenbelt, I., Pelletier, J. P., Raynauld, J. P., Reiter-Niesert, S., Rizzoli, R., Sandell, L. J., Van Spil, W. E., & Reginster, J. Y. (2014). Republished: Value of biomarkers in osteoarthritis: current status and perspectives. Postgraduate medical journal, 90(1061), 171-8. https://doi.org/10.1136/postgradmedj-2013-203726rep
Lotz, M, et al. "Republished: Value of biomarkers in osteoarthritis: current status and perspectives." Postgraduate medical journal vol. 90,1061 (2014): 171-8. doi: https://doi.org/10.1136/postgradmedj-2013-203726rep
Lotz M, Martel-Pelletier J, Christiansen C, Brandi ML, Bruyère O, Chapurlat R, Collette J, Cooper C, Giacovelli G, Kanis JA, Karsdal MA, Kraus V, Lems WF, Meulenbelt I, Pelletier JP, Raynauld JP, Reiter-Niesert S, Rizzoli R, Sandell LJ, Van Spil WE, Reginster JY. Republished: Value of biomarkers in osteoarthritis: current status and perspectives. Postgrad Med J. 2014 Mar;90(1061):171-8. doi: 10.1136/postgradmedj-2013-203726rep. PMID: 24534711; PMCID: PMC3934547.
Copy Download .nbib Format: NLM
Innovative Tools for Mechanobiology: Unraveling Outside-In and Inside-Out Mechanotransduction.

Frontiers in bioengineering and biotechnology

Mohammed D, Versaevel M, Bruyère C, Alaimo L, Luciano M, Vercruysse E, Procès A, Gabriele S.
PMID: 31380357
Front Bioeng Biotechnol. 2019 Jul 16;7:162. doi: 10.3389/fbioe.2019.00162. eCollection 2019.

Cells and tissues can sense and react to the modifications of the physico-chemical properties of the extracellular environment (ECM) through integrin-based adhesion sites and adapt their physiological response in a process called mechanotransduction. Due to their critical localization at...

Cite
Mohammed D, Versaevel M, Bruyère C, et al. Innovative Tools for Mechanobiology: Unraveling Outside-In and Inside-Out Mechanotransduction. Front Bioeng Biotechnol. 2019;7:162doi: 10.3389/fbioe.2019.00162.
Mohammed, D., Versaevel, M., Bruyère, C., Alaimo, L., Luciano, M., Vercruysse, E., Procès, A., & Gabriele, S. (2019). Innovative Tools for Mechanobiology: Unraveling Outside-In and Inside-Out Mechanotransduction. Frontiers in bioengineering and biotechnology, 7162. https://doi.org/10.3389/fbioe.2019.00162
Mohammed, Danahe, et al. "Innovative Tools for Mechanobiology: Unraveling Outside-In and Inside-Out Mechanotransduction." Frontiers in bioengineering and biotechnology vol. 7 (2019): 162. doi: https://doi.org/10.3389/fbioe.2019.00162
Mohammed D, Versaevel M, Bruyère C, Alaimo L, Luciano M, Vercruysse E, Procès A, Gabriele S. Innovative Tools for Mechanobiology: Unraveling Outside-In and Inside-Out Mechanotransduction. Front Bioeng Biotechnol. 2019 Jul 16;7:162. doi: 10.3389/fbioe.2019.00162. eCollection 2019. PMID: 31380357; PMCID: PMC6646473.
Copy Download .nbib Format: NLM
Antioxidative 1,4-Dihydropyridine Derivatives Modulate Oxidative Stress and Growth of Human Osteoblast-Like Cells In Vitro.

Antioxidants (Basel, Switzerland)

Milkovic L, Vukovic T, Zarkovic N, Tatzber F, Bisenieks E, Kalme Z, Bruvere I, Ogle Z, Poikans J, Velena A, Duburs G.
PMID: 30235855
Antioxidants (Basel). 2018 Sep 19;7(9). doi: 10.3390/antiox7090123.

Oxidative stress has been implicated in pathophysiology of different human stress- and age-associated disorders, including osteoporosis for which antioxidants could be considered as therapeutic remedies as was suggested recently. The 1,4-dihydropyridine (DHP) derivatives are known for their pleiotropic activity,...

Cite
Milkovic L, Vukovic T, Zarkovic N, et al. Antioxidative 1,4-Dihydropyridine Derivatives Modulate Oxidative Stress and Growth of Human Osteoblast-Like Cells In Vitro. Antioxidants (Basel). 2018;7(9)doi: 10.3390/antiox7090123.
Milkovic, L., Vukovic, T., Zarkovic, N., Tatzber, F., Bisenieks, E., Kalme, Z., Bruvere, I., Ogle, Z., Poikans, J., Velena, A., & Duburs, G. (2018). Antioxidative 1,4-Dihydropyridine Derivatives Modulate Oxidative Stress and Growth of Human Osteoblast-Like Cells In Vitro. Antioxidants (Basel, Switzerland), 7(9), . https://doi.org/10.3390/antiox7090123
Milkovic, Lidija, et al. "Antioxidative 1,4-Dihydropyridine Derivatives Modulate Oxidative Stress and Growth of Human Osteoblast-Like Cells In Vitro." Antioxidants (Basel, Switzerland) vol. 7,9 (2018). doi: https://doi.org/10.3390/antiox7090123
Milkovic L, Vukovic T, Zarkovic N, Tatzber F, Bisenieks E, Kalme Z, Bruvere I, Ogle Z, Poikans J, Velena A, Duburs G. Antioxidative 1,4-Dihydropyridine Derivatives Modulate Oxidative Stress and Growth of Human Osteoblast-Like Cells In Vitro. Antioxidants (Basel). 2018 Sep 19;7(9). doi: 10.3390/antiox7090123. PMID: 30235855; PMCID: PMC6162383.
Copy Download .nbib Format: NLM
[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Fardoun T, Peyronnet B, Khene Z, Mathieu R, Verhoest G, Pradère B, Masson-Lecomte A, Grassano Y, Roumiguié M, Massoud W, Abd El Fattah V, Doumerc N, Droupy S, De La Taille A, Bruyère F, Bernhard J, Vaessen C, Rouprêt M, Baumert H, Bensalah K.
PMID: 26461615
Prog Urol. 2014 Nov;24(13):823-4. doi: 10.1016/j.purol.2014.08.090. Epub 2014 Oct 30.

No abstract available.

Cite
Fardoun T, Peyronnet B, Khene Z, et al. Facteurs prédictifs de complications hémorragiques après néphrectomie partielle robot-assistée : une étude multicentrique. [Not Available]. Prog Urol. 2014;24(13):823-4doi: 10.1016/j.purol.2014.08.090.
Fardoun, T., Peyronnet, B., Khene, Z., Mathieu, R., Verhoest, G., Pradère, B., Masson-Lecomte, A., Grassano, Y., Roumiguié, M., Massoud, W., Abd El Fattah, V., Doumerc, N., Droupy, S., De La Taille, A., Bruyère, F., Bernhard, J., Vaessen, C., Rouprêt, M., Baumert, H., & Bensalah, K. (2014). Facteurs prédictifs de complications hémorragiques après néphrectomie partielle robot-assistée : une étude multicentrique. [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 24(13), 823-4. https://doi.org/10.1016/j.purol.2014.08.090
Fardoun, T, et al. "Facteurs prédictifs de complications hémorragiques après néphrectomie partielle robot-assistée : une étude multicentrique." [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie vol. 24,13 (2014): 823-4. doi: https://doi.org/10.1016/j.purol.2014.08.090
Fardoun T, Peyronnet B, Khene Z, Mathieu R, Verhoest G, Pradère B, Masson-Lecomte A, Grassano Y, Roumiguié M, Massoud W, Abd El Fattah V, Doumerc N, Droupy S, De La Taille A, Bruyère F, Bernhard J, Vaessen C, Rouprêt M, Baumert H, Bensalah K. Facteurs prédictifs de complications hémorragiques après néphrectomie partielle robot-assistée : une étude multicentrique. [Not Available]. Prog Urol. 2014 Nov;24(13):823-4. doi: 10.1016/j.purol.2014.08.090. Epub 2014 Oct 30. French. PMID: 26461615.
Copy Download .nbib Format: NLM
[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Bruyere F, Ruimy J, Elfassi R, Boyer O, Fabrice A, De Honnaville C.
PMID: 26461649
Prog Urol. 2014 Nov;24(13):839. doi: 10.1016/j.purol.2014.08.123. Epub 2014 Oct 30.

No abstract available.

Cite
Bruyere F, Ruimy J, Elfassi R, et al. Analyse des facteurs prédictifs de récidive des prostatites aiguës bactériennes communautaires au sein d'une cohorte prospective de 158 malades pris en charge en ambulatoire dans un réseau de soin. [Not Available]. Prog Urol. 2014;24(13):839doi: 10.1016/j.purol.2014.08.123.
Bruyere, F., Ruimy, J., Elfassi, R., Boyer, O., Fabrice, A., & De Honnaville, C. (2014). Analyse des facteurs prédictifs de récidive des prostatites aiguës bactériennes communautaires au sein d'une cohorte prospective de 158 malades pris en charge en ambulatoire dans un réseau de soin. [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 24(13), 839. https://doi.org/10.1016/j.purol.2014.08.123
Bruyere, F, et al. "Analyse des facteurs prédictifs de récidive des prostatites aiguës bactériennes communautaires au sein d'une cohorte prospective de 158 malades pris en charge en ambulatoire dans un réseau de soin." [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie vol. 24,13 (2014): 839. doi: https://doi.org/10.1016/j.purol.2014.08.123
Bruyere F, Ruimy J, Elfassi R, Boyer O, Fabrice A, De Honnaville C. Analyse des facteurs prédictifs de récidive des prostatites aiguës bactériennes communautaires au sein d'une cohorte prospective de 158 malades pris en charge en ambulatoire dans un réseau de soin. [Not Available]. Prog Urol. 2014 Nov;24(13):839. doi: 10.1016/j.purol.2014.08.123. Epub 2014 Oct 30. French. PMID: 26461649.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 193 entries